Animal Behavior Models in the Analysis and Understanding of Anxiolytic Drugs Acting at Serotonin Receptors

  • Chapter
Animal Models in Psychopharmacology

Part of the book series: APS: Advances in Pharmacological Sciences ((APS))

Summary

Behavioral models have been used extensively in the development and evaluation of anxiolytic drugs. The introduction of clinically-effective anxiolytic drugs that appear to function through mechanisms other than those related to benzodiazepine (BZ) compounds has resulted in a critical re-evaluation of traditional models and concepts of anxiety, as well as the introduction of new animal models. This chapter provides an overview and evaluation of current animal behavior models used in the analysis of anxiolytic drugs with a focus on novel anxiolytics acting through serotonin (5-HT) receptor systems.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Ator, N.A., Cook, J.M., Griffiths, R.R. (1989) Drug Dev. Res. 16, 257–267.

    Article  Google Scholar 

  • Barrett, J.E., Witkin, J.M., Mansbach, R.S., Skolnick, P., Weissman, B.A. (1986) J. Pharmacol. Exp. Ther. 238, 1009–1013.

    Google Scholar 

  • Barrett, J.E., Gleeson, S., Nader, M.A., Hoffmann, S.M. (1989) J. Psychopharmacol. 3, 64–69.

    Article  Google Scholar 

  • Barrett, J.E., Witkin, J.M. (1990) In: Buspirone: Mechanisms and Clinical Aspects (G. Tunnicliff, A.S. Eison and D.P. Taylor, Eds), Academic Press/Tampa, FL.

    Google Scholar 

  • Benjamin, D., Lal, H., Meyerson, L.R. (1990) Life Sci. 47, 195–203.

    Article  Google Scholar 

  • Blanchard, D.C., Rodgers, R.J., Hendrie, CA., Hori, K. (1988) Pharmacol. Biochem. Behav. 31, 269–278.

    Article  Google Scholar 

  • Brady, L.S., Barrett, J.E. (1985) J. Pharmacol. Exp. Ther. 234, 106–112.

    Google Scholar 

  • Brocco, M.J., Koek, W., Degryse, A.-D., Colpaert, F.C. (1990) Behav. Pharmacol. 1.

    Google Scholar 

  • Broekkamp, C.L.E., Berendsen, H.H.G., Jenck, F., Van Delft, A.M.L. (1989) Psychopathology 22 (suppl. 1), 2–12.

    Article  Google Scholar 

  • Cappell, H.D., LeBlanc, A.E. (1973) J. Comp. Physiol. Psychol. 83, 97–104.

    Article  Google Scholar 

  • Carli, M., Prontera, C, Samanin, R. (1989) Br. J. Pharmacol. 96, 829–836.

    Article  Google Scholar 

  • Carli, M., Samanin, R. (1988) Psychopharmacology 94, 84–91.

    Article  Google Scholar 

  • Chopin, P., Briley, M. (1987) Trends Pharmacol. Sci. 8, 383–388.

    Article  Google Scholar 

  • Charney, D.S., Woods, S.W., Goodman, W.K., Heninger, G.R. (1987) Psychopharmacology 92, 14–24.

    Article  Google Scholar 

  • Colpaert, F.C., Meert, T.F., Niemegeers, C.J.E., Janssen, P.A.J. (1985) Psychopharmacology 86, 45–54.

    Article  Google Scholar 

  • Costall, B., Domeney, A.M., Gerrard, P.A., Kelly, M.E., Naylor, R.J. (1988a) J. Pharm. Pharmacol. 40, 302–305.

    Article  Google Scholar 

  • Costall, B., Jones, B.J., Kelly, M.E., Naylor, R.J., Tomkins, D.M. (1989) Pharmacol. Biochem. Behav. 32, 777–785.

    Article  Google Scholar 

  • Costall, B., Kelly, M.E., Naylor, R.J., Onaivi, E.S. (1988b) J. Pharm. Pharmacol. 40, 494–500.

    Article  Google Scholar 

  • Craft, R.M., Howard, J.L., Pollard, G.T. (1988) Pharmacol. Biochem. Behav. 30, 775–780.

    Article  Google Scholar 

  • Crawley, J.N. (1985) Neurosci. Biobehav. Rev. 9, 37–44.

    Article  Google Scholar 

  • Critchley, M.A.E., Handley, S.L. (1987) Psychopharmacology 93, 502–506.

    Article  Google Scholar 

  • Cutler, M.G. (1990) Neuropharmacol. 29, 515–520.

    Article  Google Scholar 

  • Davis, M. (1988) Anim. Models Psychiaf. Disord. 1, 61–89.

    Google Scholar 

  • Davis, M., Cassella, J.V., Kenne, J.H. (1988) Psychopharmacology 94, 14–20.

    Article  Google Scholar 

  • Dunn, R.W., Corkett, R., Fielding, S. (1989) Eur. J. Pharmacol. 169, 1–10.

    Article  Google Scholar 

  • Engel, J.A., Hjorth, S., Svensson, K., Carlsson, A., Liljequist, S. (1984). Eur. J. Pharmacol. 105, 365–368.

    Article  Google Scholar 

  • Ervin, G.N., Cooper, B.R. (1988) J. Pharmacol. Exp. Ther. 245, 137–146.

    Google Scholar 

  • Ervin, G.N., Soroko, F.S., Cooper, B.R. (1987) Drug. Dev. Res. 11, 87–95.

    Article  Google Scholar 

  • Fernández-Guasti, A., Lopez-Rubalcava, C. (1990) Psychopharmacology 101, 354–358.

    Article  Google Scholar 

  • File, S. (1985) Neuropsychobiology 13, 55–62.

    Article  Google Scholar 

  • File, S. (1988) Anim. Models Psychiat. Disord. 1, 151–166.

    Google Scholar 

  • File, S., Johnston, A.L. (1989) Psychopharmacology 99, 248–251.

    Article  Google Scholar 

  • Gardner, C.R. (1985) J. Pharmacol. Meth. 14, 181–187.

    Article  Google Scholar 

  • Gardner, C.R. (1986) Pharmacol. Biochem. Behav. 24, 1479–1485.

    Article  Google Scholar 

  • Gardner, C.R. (1988) Gen. Pharmac. 19, 347–356.

    Article  Google Scholar 

  • Geller, I., Hartmann, R.J. (1982) J. Clin. Psychiatry 43, 25–32.

    Google Scholar 

  • Geller, I., Seifter, J. (1960) Psychopharmacologia 1, 782–492.

    Article  Google Scholar 

  • Gleeson, S., Ahlers, S.T., Mansbach, R.S., Foust, J.M., Barrett, J.E. (1989) J. Pharmacol. Exp. Ther. 250, 809–817.

    Google Scholar 

  • Gleeson, S., Barrett, J.E. (1990) Pharmacol. Biochem. Behav. 37, 335–337.

    Article  Google Scholar 

  • Glenn, B., Green, S. (1989) Behav. Pharmacol. 1, 91–94.

    Google Scholar 

  • Goa, K.L., Ward, A. (1986) Drugs 32, 114–129.

    Article  Google Scholar 

  • Goldberg, M.E., Salama, A.I., Patel, J.B., Malick, J.B. (1983) Neuropharmacology 22, 1499–1504.

    Article  Google Scholar 

  • Gower, A.J., Tricklebank, M.D. (1988) Eur. J. Pharmacol. 155, 129–137.

    Article  Google Scholar 

  • Graeff, F. (1987) In: Advances in Behavioral Pharmacology (T. Thompson, P.B. Dews and J.E. Barrett, Eds), Lawrence Erlbaum/Hillsdale, NJ, pp 129–156.

    Google Scholar 

  • Guy, A.P., Gardner, C.R. (1985) Neuropsychobiology 13, 194–200.

    Article  Google Scholar 

  • HĂĄrd, E., Engel, J. (1988) Neuropharmacol. 27, 981–986.

    Article  Google Scholar 

  • Hodges, H., Green, S., Glenn, B. (1987) Psycfiopharmacology 92, 491–504.

    Google Scholar 

  • Howard, J.L., Nanry, K.P., Perkins, A.N., Thomas, J.D. (1990) Faseb J. 4, A616.

    Google Scholar 

  • Howard, J.L., Pollard, G.T. (1990) Drug Dev. Res. 19, 37–49.

    Article  Google Scholar 

  • Insel, T.R., Gelhard, R.E., Miller, L.P. (1990) Dev. Psychobiol. 22, 509–525.

    Article  Google Scholar 

  • Jenck, F., Broekkamp, C.L.E., Van Delft, A.M.L. (1989a) Psycfiopharmacology 97, 489–495.

    Article  Google Scholar 

  • Jenck, F., Broekkamp, C.L.E., Van Delft, A.M.L. (1989b) Eur. J. Pharmacol. 161, 219–221.

    Article  Google Scholar 

  • Jenck, F., Broekkamp, C.L.E., Van Delft, A.M.L. (1990a) Psychopharmacology 100, 372–376.

    Article  Google Scholar 

  • Jenck, F., Broekkamp, C.L.E., Van Delft, A.M.L. (1990b) Eur. J. Pharmacol. 197, 201–204.

    Article  Google Scholar 

  • Jones, B.J., Costall, B., Domeney, A.M., Kelly, M.E., Naylor, R.J., Oakley, N.R., Tyers, M.B. (1988) Br. J. Pharmacol. 93, 985–993.

    Article  Google Scholar 

  • Kennett, G.A., Whitton, P., Shah, K., Curzon, G. (1989) Eur. J. Pharmacol. 164, 445–454.

    Article  Google Scholar 

  • Kostowski, W., Plaznik, A., Stefanski, R. (1989) Eur. J. Pharmacol. 168, 393–396.

    Article  Google Scholar 

  • Lal, H., Emmett-Oglesby, M.W. (1983) Neuropharmacol. 22, 1423–1441.

    Article  Google Scholar 

  • Lecci, A., Borsini, F., Volterra, G., Meli, A. (1990) Psychopharmacology 101, 255–261.

    Article  Google Scholar 

  • Lister, R.G. (1990) Pharmac. Ther. 46, 321–340.

    Article  Google Scholar 

  • Mansbach, R.S., Geyer, M.A. (1988) Eur. J. Pharmacol. 156, 375–383.

    Article  Google Scholar 

  • Mansbach, R.S., Harrod, C, Hoffmann, S.M., Nader, M.A., Lei, Z., Witkin, J.M., Barrett, J.E. (1988) J. Pharmacol. Exp. Ther. 246, 114–120.

    Google Scholar 

  • Mason, S.T., Skinner, J., Luttinger, D. (1987) Psychopharmacology 92, 30–34.

    Article  Google Scholar 

  • McCloskey, T.C., Paul, B.K., Commissaris, R.L. (1987) Pharmacol. Biochem. Behav. 27, 171–175.

    Article  Google Scholar 

  • Meert, T.F., Colpaert, F.C. (1986) Psychopharmacology 88, 445–450.

    Article  Google Scholar 

  • Meert, T.F., Janssen, P.A.J. (1989) Drug Dev. Res. 18, 119–144.

    Article  Google Scholar 

  • Merlo Pich, E.M., Samanin, R. (1986) Psychopharmacology 89, 125–130.

    Google Scholar 

  • Mos, J., v.d. Heyden, J., Olivier, B. (1989) In: Behavioural Pharmacology of 5-HT (P. Bevan, A.R. Cools and T. Archer, Eds), Lawrence Erlbaum/Hillsdale, N.J., pp 389–395.

    Google Scholar 

  • Mos, J., Olivier, B. (1989) In: Behavioural Pharmacology of 5-HT (P. Bevan, A.R. Cools and T. Archer, Eds), Lawrence Erlbaum/Hillsdale, N.J., pp 361–366.

    Google Scholar 

  • Moser, P.C. (1989) Psychopharmacology 99, 48–53.

    Article  Google Scholar 

  • Moser, P.C., Tricklebank, M.D., Middlemiss, D.N., Mir, A.K., Hibert, M.F., Fozard, J.R. (1990) Br. J. Pharmacol. 99, 343–349.

    Article  Google Scholar 

  • Oakley, N.R., Jones, B.J. (1983) Eur. J. Pharmacol. 87, 499–500.

    Article  Google Scholar 

  • Olivier, B., Mos, J., Tulp, M., Schipper, J., Bevan, P. (1989) In: Behavioural Pharmacology of 5-HT (P. Bevan, A.R. Cools & T. Archer, Eds), Lawrence Erlbaum/Hillsdale, N.J., pp 89–115.

    Google Scholar 

  • Onaivi, E.S., Martin, B.R. (1990) Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 13, 963–976.

    Article  Google Scholar 

  • Papp, M., Przegalinski, E. (1989) J. Psychopharmacol. 3, 14–20.

    Article  Google Scholar 

  • Pellow, S. (1986) Meth. Find. Exptl. Clin. Pharmacol. 8, 557–565.

    Google Scholar 

  • Pellow, S., Chopin, P., File, S., Briley, M. (1985) J. Neurosci. Meth. 14, 149–167.

    Article  Google Scholar 

  • Pellow, S., File, S.E. (1986) Pharmacol. Biochem. Behav. 24, 525–529.

    Article  Google Scholar 

  • Pollard, G.T., Howard, J.L. (1990) Pharmacol. Ther. 45, 403–424.

    Article  Google Scholar 

  • Przegalinski, E., Tatarczynska and Chojnacka-WĂłjcik (1989) J. Psychopharmacol. 3, 180–185.

    Article  Google Scholar 

  • Rohmer, J.-G., Di Scala, G., Sander, G. (1990) Behav. Brain Res. 38, 45–54.

    Article  Google Scholar 

  • Sanger, D.J., Joly, D., Zivkovic, B. (1985) J. Pharmacol. Exp. Ther. 232, 831–837.

    Google Scholar 

  • Schefke, D.M., Fontana, D.J., Commissaris, R.L. (1989) Psychopharmacology 99, 427–429.

    Article  Google Scholar 

  • Sepinwall, J. (1985) In: Behavioral Pharmacology: The Current Status (L.S. Seiden and R.L. Balster, Eds), Alan R. Liss/New York, pp. 181–203.

    Google Scholar 

  • Shimizu, H., Hirose, A., Tatsuno, T., Nakamura, M., Katsube, J. (1987) Jap. J. Pharmacol. 45, 493–500.

    Article  Google Scholar 

  • Söderpalm, B., Rjorth, S., Engel, J.A. (1989) Pharmacol. Biochem. Behav. 32, 259–265.

    Article  Google Scholar 

  • Stephens, D.N., Kehr, W., Schneider, H.H., and Schmiechen, R. (1984) Neurosci. Lett. 47, 333–338.

    Article  Google Scholar 

  • Treit, D. (1985) Neurosci. Biobehav. Rev. 9, 203–222.

    Article  Google Scholar 

  • Treit, D. (1990) Pharmacol. Biochem. Behav. 36, 203–205.

    Article  Google Scholar 

  • Treit, D., Fundytus, M. (1988) Pharmacol. Biochem. Behav. 30, 1071–1075.

    Article  Google Scholar 

  • Vellucci, S.V., Martin, P.J., Everitt, B.J. (1988) J. Psychopharmacol. 2, 80–93.

    Article  Google Scholar 

  • Vogel, J.R., Beer, B., Clody, D.E. (1971) Psychopharmacologia 21, 1–7.

    Article  Google Scholar 

  • Weissman, B.A., Barrett, J.E., Brady, L.S., Witkin, J.M., Mendelson, W.B., Paul, S.M., Skolnick, P. (1984) Drug Dev. Res. 4, 83–93.

    Article  Google Scholar 

  • Wettstein, J.G. (1988) Eur. J. Pharmacol. 151, 341–344.

    Article  Google Scholar 

  • Winter, J.C. (1988) Pharmacol. Biochem. Behav. 29, 193–195.

    Article  Google Scholar 

  • Winter, J.C, Rabin, R.A. (1989) Drug. Dev. Res. 16, 327–333.

    Article  Google Scholar 

  • Witkin, J.M., Barrett, J.E. (1986) Pharmacol. Biochem. Behav. 24, 751–756.

    Article  Google Scholar 

  • Witkin, J.M., Perez, L.A. (1990) Behav. Pharm. 1, 247–254.

    Google Scholar 

  • Young, R., Urbancic, A., Emrey, T.A., Hall, P.C., Metcalf, G. (1987) Eur. J. Pharmacol. 143, 361–371.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Basel AG

About this chapter

Cite this chapter

Barrett, J.E. (1991). Animal Behavior Models in the Analysis and Understanding of Anxiolytic Drugs Acting at Serotonin Receptors. In: Olivier, B., Mos, J., Slangen, J.L. (eds) Animal Models in Psychopharmacology. APS: Advances in Pharmacological Sciences. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-6419-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-6419-0_3

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-6421-3

  • Online ISBN: 978-3-0348-6419-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Navigation